Table 1.
Basic characteristics of the included trials.
| References | Sample size (T/C) | Age (years) | Diagnostic criteria | Intervention | Control | Treatment duration |
|---|---|---|---|---|---|---|
| Dong et al. 2009 [24] | 46/45 | 49.7±14.5 | CGMH-2005 | CS 60g/d + C | Hypotensive drugs | 12 weeks |
| Yu 2017 [22] | 51/51 | 57.2±3.5 | CGMH-2005 | CS 60g/d + C | Nifedipine controlled released tablets (0.03g q.d.) | 12 weeks |
| Gu and Tan 2015 [23] | 32/32 | 65.1± 8.8 | CGMH-2010 | Modified CST (CS 10g)+ C | Enalapril tablets (10mg q.d.) Folic acid tablets (0.8mg q.d.) | 8 weeks |
| Liu and Jin 2017 [21] | 104/102 | 30±0.5 | CGMGH-2012 | CS 50g/d + C | Hypotensive drugs | 1 weeks |
| Guli et al. 2017 [25] | 53/51 | 29±0 | CGMGH-2012 | CS 50g/d + C | Hypotensive drugs | 1 weeks |
CN: China; CS: corn silk; CST: corn silk tea; T: treating group; C: control group; CGMGH: Chinese Guidelines for the Management of Gestational Hypertension; CGMH: Chinese Guidelines for the Management of Hypertension.